NEFL and obstructive sleep apnea syndrome: The diagnostic discriminatory ability of the biomarker within the context of OSA was assessed as good with the area under the curve of 0.816 and with the use of a cutoff value of NfL of 18.75 pg/ml, resulting in 89.3% sensitivity and 61.2% specificity.